Lavaca Capital LLC Abbott Laboratories Transaction History

Lavaca Capital LLC

$233 Million
Q3 2024

A detailed history of Lavaca Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Lavaca Capital LLC holds 3,746 shares of ABT stock, worth $434,273. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,746

Previous 3,739 0.19%

Holding current value

$434,273

Previous $388,000 10.05%

% of portfolio

0.18%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $700 - $826	7 Added 0.19%	3,746 $427,000
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $281,338 - $314,044	-2,793 Reduced 42.76%	3,739 $388,000
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $32,965 - $36,408	301 Added 4.83%	6,532 $742,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $528,603 - $647,054	-5,861 Reduced 48.47%	6,231 $685,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $55,311 - $66,364	-579 Reduced 4.57%	12,092 $1.17 Million
Q2 2023 Aug 25, 2023	BUY	$100.78 - $112.29 $1.28 Million - $1.42 Million	12,671 New	12,671 $1.38 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $58,794 - $69,204	607 Added 3.85%	16,355 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $268,544 - $315,044	2,825 Added 21.86%	15,748 $1.73 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $530,535 - $614,260	-5,483 Reduced 29.79%	12,923 $1.32 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $143,918 - $173,951	1,410 Added 8.3%	18,406 $2.03 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $1.37 Million - $1.67 Million	-11,993 Reduced 41.37%	16,996 $2.01 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $22,297 - $27,301	-193 Reduced 0.66%	28,989 $4.08 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $246,619 - $272,832	2,114 Added 7.81%	29,182 $3.45 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $159,002 - $187,168	1,503 Added 5.88%	27,068 $3.14 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $634,754 - $747,837	5,832 Added 29.55%	25,565 $3.06 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $147,000 - $160,188	1,400 Added 7.64%	19,733 $2.16 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $174,116 - $211,451	1,900 Added 11.56%	18,333 $2 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $20,673 - $26,460	270 Added 1.67%	16,433 $1.5 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $39,011 - $57,045	-621 Reduced 3.7%	16,163 $1.28 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $10,932 - $12,750	-150 Reduced 0.89%	16,784 $1.41 Million
Q4 2018 Jan 22, 2019	BUY	$65.56 - $74.27 $1.11 Million - $1.26 Million	16,934 New	16,934 $1.23 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lavaca Capital LLC with notifications on news.

Account

Lavaca Capital LLC Abbott Laboratories Transaction History